Pradaxa® Named ‘Most Complained About Drug’ in the U.S.

February 19th, 2014 | Drug injury

Medications that are distributed to patients in the United States must undergo rigorous testing regulated by the U.S. Food and Drug Administration in order to ensure the products are safe for consumers; however, medications are sometimes approved that can still be dangerous to consumers. Take the medication Pradaxa® as a fine example. The drug is… Read More

FDA And Drug Manufacturer Issue Recall Due To Contamination

January 11th, 2013 | Drug injury

January 11, 2013 The U.S. Food and Drug Administration (FDA) announced earlier this week that it had partnered with Mobius Therapeutics, LLC, in issuing a voluntary market recall of the company’s Mitosol® (mitomycin for solution), 0.2 mg/vial, kit for ophthalmic use. According to a press release from the agency, the recall was issued due to a possible… Read More

Ohio To Receive $1.4 Million From Drug Settlement

October 26th, 2012 | Drug injury

October 26, 2012 Ohio is set to receive a large portion of a settlement that was reached in connection to a lawsuit filed against drug manufacturing giant, Boehringer Ingelheim Pharmaceuticals Inc. (BIPI). The Dayton Business Journal reports the lawsuit was filed amid allegations the company had engaged in illegal marketing campaigns for certain medications and was… Read More